Cardiac ischemia during hemolytic uremic syndrome

Pediatric Nephrology

Volumn 18, Issue 3, 2003, Pages 286-289

  Thayu, Meena ^a,b   Chandler, Wayne L ^a   Jelacic, Srdjan ^a,c   Gordon, Carrie A ^a,c   Rosenthal, Geoffrey L ^c,d   Tarr, Phillip I ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Creatine kinase MB mass; Escherichia coli O157:H7; Hemolytic uremic syndrome; Myocardial ischemia; Troponin I

Indexed keywords

ADRENALIN; CREATINE KINASE MB; DOPAMINE; HEMOGLOBIN; LOPERAMIDE; OXYGEN; TROPONIN I;

ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON PERFORATION; COLON RESECTION; COLOSTOMY; DIARRHEA; ECHOCARDIOGRAPHY; ESCHERICHIA COLI O157; FIBRINOLYSIS; GLOMERULOSCLEROSIS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPOTENSION; MALE; METABOLIC ACIDOSIS; PANCREATITIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; THROMBIN TIME;

EID: 0037821843     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-1039-3     Document Type: Article

References (19)

1. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930-1936
2. Tsai HM, Chandler WL, Sarode R, Hoffman R, Jelacic S, Habeeb R, Watkins SL, Wong CS, Williams GD, Tarr PI (2001) von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49:653-659
3. Habib R (1992) Pathology of the hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Dekker, New York, pp 315-353
4. Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI (2002) Prothrombotic coagulation abnormalities associated with Escherichia coli O157:H7 infections. N Engl J Med 346:23-32
5. Bergstein JM, Riley BS, Bang NU (1992) Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 327:755-759
6. Kar NC van de, Hinsbergh VW van, Brommer EJ, Monnens LA (1994) The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. Pediatr Res 36:257-264
7. Nevard CH, Jurd KM, Lane DA, Philippou H, Haycock GB, Hunt BJ (1997) Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost 78:1450-1455
8. Chant ID, Milford DV, Rose PE (1994) Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome. QJM 87:737-740
9. Smith JM, Jones F, Ciol MA, Jelacic S, Boster DR, Watkins SL, Tarr PI, Henderson WR Jr (2003) Platelet-activating factor and Escherichia coli O157:H7 infections. Pediatr Nephrol (in press)
10. Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, Avner ED (1994) Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 125:519-526
11. Collinson PO, Wiggins N, Gaze DC (2001) Clinical evaluation of the ACS:180 cardiac troponin I assay. Ann Clin Biochem 38:509-519
12. Tun A, Khan IA, Win MT, Hussain A, Hla TA, Wattanasuwan N, Vasavada BC, Sacchi TJ (1998) Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology 90:280-285
13. Eckart P, Guillot M, Jokic M, Maragnes P, Boudailliez B, Palcoux JB, Desvignes V (1999) Cardiac involvement during classic hemolytic uremic syndrome. Fr Arch Pediatr 6:430-433
14. Ramirez J, Zgaib S, Miguel R de, Ferraris J, Persico R, Graca IZ da, Gianantonio C (1989) Activity of creatine kinase and its isoenzymes in hemolytic uremic syndrome. Medicina (B Aires) 49:285-292
15. Munger MA, Ateshkadi A, Cheung AK, Flaharty KK, Stoddard GJ, Marshall EH (2000) Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36:130-139
16. Robson WL, Leung AK, Montgomery MD (1991) Causes of death in hemolytic uremic syndrome. Child Nephrol Urol 11:228-233
17. Deegan PB, Lafferty ME, Blumshon A, Henderson IA, McGregor E (2001) Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 60:2399-2405
18. Apple FS (1997) Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 29:399-403
19. Iliou M, Fumeron C, Benoit MO, Tuppin P, Le Courvoisier C, Calogne VM, Moatti N, Buisson D, Jacquot C (2001) Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaulation (CHANCE) study. Nephrol Dial Transplant 16:1452-1458